During the progression of Alzheimer’s disease, microglial cells located in the vicinity of plaques become overactivated and release cytotoxic mediators such as TNFα. In an animal study published in 2025, Nguyen et al. were able to show, among other things, that increased TNFα levels in 5xFAD mice could be normalized by a five-week administration of EGb-761®-containing feed and that an influence on microglia subpopulations contributed to this effect.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- "Swiss Health Care Atlas"
New indicator: medication for weight regulation
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- Treatment of pancreatitis: current study data
How can the risk-benefit profile be improved?
- Prurigo and PN
Anti-inflammatory antipruritic therapy improves quality of life
- Pathophysiology, clinical significance and therapeutic consequences
Eosinophils in asthma
- Urothelial carcinoma
Perioperative innovations and organ-preserving strategies
- Artificial intelligence
Dr. ChatGPT: Large language models in everyday clinical practice
- GLA:D® program for back pain patients